CELL INTELLIGENCE · 肿瘤细胞治疗研究

用于癌症过继性细胞治疗的细胞类型定制水凝胶

Cell-Type-Tailored Hydrogels for Adoptive Cell Therapy in Cancer.

用于癌症免疫治疗的异体 T 细胞平台的工程化策略

Engineering Strategies for Allogeneic T Cell-Based Platforms in Cancer Immunotherapy.

人γδ T 细胞疗法治疗胶质母细胞瘤：克服过继性免疫细胞治疗挑战的新型替代方案

Human gamma-delta (γδ) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy.

原发性皮肤γδ T 细胞淋巴瘤的临床异质性：一项 20 年单中心经验

Clinical heterogeneity of primary cutaneous γδ T-cell lymphoma: a 20-year single-institution experience.

PCGDTCL 似乎表现出比以往认识到的更广泛的临床和治疗异质性。部分患者的持久缓解提示，治疗反应性可能在整个疾病谱中有所不同。

肿瘤微环境中的人 γδ T 细胞：推进癌症免疫治疗的关键见解

Human γδ T cells in the tumor microenvironment: Key insights for advancing cancer immunotherapy.

γδ T 细胞作为胶质母细胞瘤的潜在治疗剂

γδ T cells as a potential therapeutic agent for glioblastoma.

人同种异体γδ T 细胞杀伤高表达 DNAM-1 配体的患者来源胶质母细胞瘤细胞

Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands.

体外扩增γδ T 细胞对骨肉瘤细胞的治疗潜力

Therapeutic Potential of Ex Vivo Expanded γδ T Cells against Osteosarcoma Cells.

Tafasitamab 联合 γδ T 细胞或异体 NK 细胞治疗介导 B 细胞非霍奇金淋巴瘤杀伤

Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy.

通过全身递送一种增强免疫的表皮葡萄球菌菌株来增强黑色素瘤治疗

Enhancing melanoma treatment through systemic delivery of an immune boosting Staphylococcus epidermidis strain.